110.12
1.28 (1.18%)
1.28 (1.18%)
Upgrade to Real-Time
Afterhours
| Volume | 16,714,138 |
|
|||||
| News | - | ||||||
| Day High | 110.33 | Low High |
|||||
| Day Low | 107.63 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.28 | 1.18% | 110.12 | 16:08:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 108.70 | 107.63 | 110.33 | 110.12 | 108.84 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 103,664 | 16,714,138 | $ 108.65 | $ 1,816,039,899 | - | 71.50 - 110.33 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:08:45 | 65 | $ 110.12 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 278.16B | 2.54B | 2.53B | $ 50.16B | $ 12.97B | 5.14 | 18.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.64 | 2.54% | 09/14/22 | 157.70k | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 106.38 | 110.33 | 106.3003 | 108.14 | 6,953,464 | 3.74 | 3.52% |
| 1 Month | 99.65 | 110.33 | 97.33 | 102.34 | 8,935,935 | 10.47 | 10.51% |
| 3 Months | 86.43 | 110.33 | 84.52 | 94.71 | 9,034,427 | 23.69 | 27.41% |
| 6 Months | 91.83 | 110.33 | 83.05 | 91.99 | 9,493,463 | 18.29 | 19.92% |
| 1 Year | 74.70 | 110.33 | 71.50 | 85.75 | 10,995,192 | 35.42 | 47.42% |
| 3 Years | 87.52 | 110.33 | 65.25 | 81.39 | 11,095,697 | 22.60 | 25.82% |
| 5 Years | 55.42 | 110.33 | 52.83 | 77.56 | 10,729,129 | 54.70 | 98.7% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States. |